Viewing Study NCT06315205


Ignite Creation Date: 2025-12-25 @ 3:19 AM
Ignite Modification Date: 2026-03-08 @ 3:30 AM
Study NCT ID: NCT06315205
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-03
First Post: 2024-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women
Sponsor: Rovi Pharmaceuticals Laboratories
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module